Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Alginate antibody

Reactivity: Pseudomonas ELISA Host: Mouse Monoclonal 3G4-1F5 unconjugated
Catalog No. ABIN7489925
  • Target
    Alginate
    Reactivity
    Pseudomonas
    Host
    • 10
    Mouse
    Clonality
    • 10
    Monoclonal
    Conjugate
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Un-conjugated
    Application
    • 10
    • 10
    ELISA
    Cross-Reactivity
    Pseudomonas
    Immunogen
    Sodium alginate conjugated to KLH
    Clone
    3G4-1F5
    Isotype
    IgG1
  • Application Notes
    ELISA: Use at 0.5-20 μg/mL with alginate on the solid phase. Working concentrations for these antibodies are dependent on the purity and concentration of alginate in samples tested.
    Comment

    Anti-Alginate Mouse Monoclonal Antibody

    Restrictions
    For Research Use only
  • Format
    Liquid
    Reconstitution
    Dilute in PBS or medium that is identical to that used in the assay system.
    Concentration
    Lot specific
    Buffer
    50 % Glycerol,PBS, pH 7.4, 50 % glycerol, 0.1 % sodium azide.,Phosphate Buffered Saline
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C
    Storage Comment
    These antibodies are stable for at least one (1) year at -20°C. Store in appropriate aliquots to avoid multiple freeze-thaw cycles.
  • Target
    Alginate
    Target Type
    Chemical
    Background
    Pulmonary infection by mucoid, alginate-producing Pseudomonas aeruginosa is the leading cause of mortality among patients suffering from cystic fibrosis. During early childhood, cystic fibrosis patients are colonized by multiple bacterial pathogens including nonmucoid P. aeruginosa. The appearance of mucoid isolates indicates progression to chronic infections. Recent evidence indicates that P. aeruginosa is most resistant to antibiotics when the infecting cells are present as a biofilm, as they appear to be in the lungs of cystic fibrosis patients.
You are here:
Support